TMEM131 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.183800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.029000E-01
Normal-vs-Stage2
5.192800E-01
Normal-vs-Stage3
1.670770E-01
Normal-vs-Stage4
6.206000E-01
Stage1-vs-Stage2
6.077200E-01
Stage1-vs-Stage3
5.282200E-02
Stage1-vs-Stage4
9.056000E-01
Stage2-vs-Stage3
6.307600E-02
Stage2-vs-Stage4
5.912000E-01
Stage3-vs-Stage4
3.180400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.208200E-01
Normal-vs-AfricanAmerican
3.333800E-01
Normal-vs-Asian
4.556000E-01
Caucasian-vs-AfricanAmerican
9.356200E-01
Caucasian-vs-Asian
4.397000E-01
AfricanAmerican-vs-Asian
6.883600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.359400E-01
Normal-vs-Female
4.993600E-01
Male-vs-Female
4.503400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.899800E-01
Normal-vs-Age(41-60Yrs)
5.951600E-01
Normal-vs-Age(61-80Yrs)
4.787000E-01
Normal-vs-Age(81-100Yrs)
5.662400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.096200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.515800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.377800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.830220E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.054000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.122600E-01
Normal-vs-Daily Drinker
4.898000E-01
Normal-vs-Weekly Drinker
2.899400E-01
Normal-vs-Occasional Drinker
6.340000E-01
Normal-vs-Social Drinker
5.016600E-01
Non Drinker-vs-Daily Drinker
3.551400E-01
Non Drinker-vs-Weekly Drinker
1.942180E-01
Non Drinker-vs-Occasional Drinker
2.447800E-02
Non Drinker-vs-Social Drinker
3.607000E-01
Daily Drinker-vs-Weekly Drinker
5.814600E-01
Daily Drinker-vs-Occasional Drinker
1.670970E-01
Daily Drinker-vs-Social Drinker
9.226400E-01
Weekly Drinker-vs-Occasional Drinker
5.725600E-01
Weekly Drinker-vs-Social Drinker
6.750400E-01
Occasional Drinker-vs-Social Drinker
2.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.701800E-01
Normal-vs-Grade 2
6.467200E-01
Normal-vs-Grade 3
6.481800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.834800E-01
Grade 1-vs-Grade 3
7.154200E-01
Grade 1-vs-Grade 4
6.701800E-01
Grade 2-vs-Grade 3
9.776200E-01
Grade 2-vs-Grade 4
6.467200E-01
Grade 3-vs-Grade 4
6.481800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.688200E-01
Normal-vs-NonDiabetic
5.091200E-01
Diabetic-vs-NonDiabetic
4.425800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.282800E-01
Normal-vs-NoPancreatitis
5.082400E-01
Pancreatitis-vs-NoPancreatitis
3.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.230200E-01
Normal-vs-N1
5.142600E-01
N0-vs-N1
8.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.878400E-01
Normal-vs-TP53-NonMutant
5.834600E-01
TP53-Mutant-vs-TP53-NonMutant
9.460200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
